Compare WEYS & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEYS | SOPH |
|---|---|---|
| Founded | 1906 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.9M | 231.8M |
| IPO Year | N/A | 2021 |
| Metric | WEYS | SOPH |
|---|---|---|
| Price | $30.06 | $4.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 20.8K | ★ 132.8K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | ★ $279,843,000.00 | $73,297,000.00 |
| Revenue This Year | N/A | $16.60 |
| Revenue Next Year | N/A | $19.09 |
| P/E Ratio | $11.93 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $25.51 | $2.58 |
| 52 Week High | $38.24 | $5.30 |
| Indicator | WEYS | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 60.31 |
| Support Level | $28.69 | $3.83 |
| Resistance Level | $30.73 | $4.70 |
| Average True Range (ATR) | 1.35 | 0.33 |
| MACD | -0.12 | 0.06 |
| Stochastic Oscillator | 37.48 | 93.22 |
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.